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ABSTRACT It has been suggested that Lys-430 of band 3, with which eosin-5-maleimide (EM) reacts, is located in the
external channel through which anions gain access to the external transport site, and that EM inhibits anion exchange by
blocking this channel. To test this, we have used 35CI nuclear magnetic resonance (NMR) to measure Cl- binding to the
external transport site in control and EM-treated human red blood cells. Intact cells were used rather than ghosts, because
in this case all line broadening (LB) results from binding to external sites. In an NMR spectrometer with a 9.4-T magnetic field,
red blood cells at 50% concentration (v/v) in 150 mM Cl- medium at 30C caused 19.0 ± 1.2 Hz LB. Of this, 7.9 ± 0.7 Hz was
due to Cl- binding to the high affinity band 3 transport sites, because it was prevented by an apparently competitive inhibitor
of anion exchange, 4,4'-dinitrostilbene-2,2'-disulfonate (DNDS). The LB was not due to hemoglobin released from the cells,
as little LB remained in the supernatant after cells were removed by centrifugation. Saturable Cl- binding remained in
EM-treated cells, although the binding was no longer DNDS-sensitive, because EM prevents binding of DNDS. The lower limit
for the rate at which CI- goes from the binding site to the external medium is 2.15 x 105 S-1 for control cells and 1.10 x 105
S1 for EM-treated cells, far higher than the Cl- translocation rate at 30C (about 400 s-1). Thus, EM does not inhibit Cl-
exchange by blocking the external access channel. EM may therefore be useful for fixing band 3 in one conformation for
studies of Cl- binding to the external transport site.
INTRODUCTION
Band 3 is a 101,700-Da integral membrane protein in hu-
man erythrocytes. A major function of band 3 is to mediate
a tightly coupled one-for-one anion exchange across the
membrane (Knauf, 1989; Jennings, 1992a,b). Eosin-5-ma-
leimide (EM) labels Lys-430 of band 3 (Cobb and Beth,
1990) and inhibits the anion exchange process (Nigg et al.,
1979). EM labels band 3 with -1:1 stoichiometry and is
widely used as a fluorescence probe for measuring rota-
tional diffusion of band 3 (Cherry, 1979). Covalent reaction
of EM with band 3 takes place only after EM is reversibly
bound (Liu and Knauf, 1993). The reversible binding also
inhibits Cl- exchange, but the inhibition is partial (Knauf et
al., 1993b). Although the bound EM appears to overlap the
binding site of some apparently competitive inhibitors such
as stilbene disulfonic acids (Cobb and Beth, 1990), the
reversible inhibition is non-competitive (Knauf et al.,
1993b). In addition, Passow et al. (1992) showed that mu-
tation of the corresponding lysine residue (Lys-449) on
mouse band 3 did not prevent Cl- binding and transport.
Therefore, EM does not block transport by binding to the
Cl- transport site.
A different mechanism of EM inhibition was suggested
on the basis that external Cl- ions gain access to the
transport site by diffusing through a channel in the band 3
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protein (Fig. 1). The external anion access channel was first
proposed by Rao et al. (1979) on the basis of fluorescence
energy transfer data that show that the stilbene disulfonate
binding site, used as a marker for the transport site, is in the
interior of the membrane bilayer. The existence of the
external anion access channel is also supported by Jennings'
(1992c; Jennings et al., 1990) data indicating that sulfate
ions traverse part of the transmembrane electric field on
their way to the external binding site. Some nuclear mag-
netic resonance (NMR) data showing that the transport site
is protected from proteolysis (Falke et al., 1985b) also
suggest that there is an anion access channel. Falke and
Chan (1986b) showed that some inhibitors, such as 1,2-
cyclohexanedione and dipyridamole, act by blocking this
access channel.
Passow et al. (1992) suggested that the residue with
which EM reacts might be located in the external anion
access channel, based on the fact that Lys-430 is located
toward the outer surface of the membrane and there is an
overlap between EM and 4,4'-diisothiocyano-dihydrostil-
bene-2,2'-disulfonate (H2DIDS, a disulfonic stilbene inhib-
itor that belongs to the same family of inhibitors as 4,4'-
dinitrostilbene-2,2'-disulfonate (DNDS)) binding. Because
of this location, they proposed that EM and other reagents
that bind to nearby sites might cause "inhibition by binding
to access channel and ensuing blockage of access to T"
(p. 95) (the transfer site), as shown schematically in Fig. 1.
They also included the alternate possibility that EM binding
has an allosteric effect on the transport site. Wyatt and
Cherry (1992) explained the partial protection of bound EM
from fluorescence-quenching agents present in the extracel-
lular medium by proposing that EM is bound in a cleft in
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FIGURE 1 Channel blocker model
of EM inhibition. The binding of EM
blocks the external anion access
channel.
Outer surface
Inner surface
band 3, which might correspond to the access channel for
external anions. This concept was used to explain the effects
of membrane potential on quenching and on EM reaction
rate. This model, like that of Passow et al. (1992), implies
that EM might block the access channel and thereby prevent
external Cl- from reaching the external anion transport site.
The binding of 35Cl to macromolecules can be detected
by NMR, because the spectral linewidth of bound Cl- is
much greater than that of free Cl- in solution. In our case,
the free Cl- in solution is always in great molar excess
relative to the bound Cl-, and the free Cl- exchanges with
bound Cl . The 35CI spectra we observe are actually the
signals of free Cl- in solution with its linewidth broadened
because of the exchange of free Cl- with Cl- in the bound
state. The line broadening (LB) of the NMR spectrum
caused by binding to a macromolecule is proportional to the
ratio of bound to total Cl- concentration, which is given by
Falke et al. (1984a,b):
LB = a * PB _ 1 [Cl]B _ [X] 1[Cl]T [Cl] + Kd
where rC1]B is the bound Cl- concentration and [C1]T is the
total Cl- concentration, which is nearly identical to the Cl-
concentration of the medium, [Cl], under the conditions
where [Cl]T» [C1]B. Kd is the dissociation constant of the
binding site, [X] is the concentration of the binding site,
which is proportional to cell concentration, a is a propor-
tionality constant, and PB is the probability of finding Cl-
in the bound state. In our study, LB was calculated by
subtracting buffer linewidth from total linewidth of the
sample.
NMR provides a way to measure the binding of substrate
even when the translocation is inhibited. Thus, NMR is
particularly useful to study the effect of inhibitors on the
binding of substrate, whether the exchange is stopped or not
* TRANSPORT SITE :
(Falke and Chan, 1986a,b,c). This is a great advantage over
the radioactive tracer flux method normally used to study
the anion transport system, and makes it possible to inves-
tigate the mechanism of irreversible EM inhibition in detail,
because binding of Cl- to the transport site can be measured
even when transport is completely inhibited by covalent
reaction with EM. As pointed out by Falke and Chan
(1986a,b,c), either a channel blocker type inhibitor or a
transport site inhibitor (competitive inhibitor) will eliminate
the LB caused by Cl- binding to the transport sites. On the
contrary, a translocation inhibitor, which inhibits by pre-
venting the transporting conformational change of band 3,
will not eliminate transport site LB.
In this study, we measured the LB of EM-treated intact
red blood cells at various Cl- concentrations. EM treatment
did not significantly decrease total LB of the red cells, and
the LB was still sensitive to changes in Cl- concentration,
indicating a saturable binding site. We have also tested the
effect of a competitive substrate, iodide, on the Cl- LB of
control and EM-treated cells. The results also support the
idea that the transport site is still accessible to external
medium after EM reacts with band 3.
Finally, we estimated the Cl- exchange rate between
medium and the binding sites. The difference between con-
trol and EM-treated samples was small, demonstrating that
EM could not inhibit Cl- transport by slowing down the
Cl- exchange between the transport site and the external
medium. A preliminary report of some of these results has
appeared in abstract form (Liu et al., 1994).
MATERIALS AND METHODS
Cell preparation
Red blood cells were obtained from freshly drawn blood, donated by
apparently healthy volunteers. Heparin was added as anticoagulant. The
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cells were washed at least 3 times with 150 KH (150 mM KCl, 24 mM
sucrose, 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid), 5 mM glucose). For each wash, the cells were centrifuged for 5 min
at 7,000 rpm; then the supernatant and buffy coat were removed by
aspiration. The cells were then subjected to different treatments as de-
scribed in the text and figure legends. The cells were stored on ice before
NMR measurement. The pH of all media used in the experiments was
adjusted to 6.9 at room temperature. Most of the measurements were
completed within 36 h after the blood had been drawn.
35CI NMR spectroscopy
Most of the NMR measurements were performed on a Bruker/GE Omega
NMR spectrometer (Fremont, CA) operating at a frequency of 39.2 MHz
for 35CI (400 MHz for protons). A 10 mm diameter broad-band tunable
probe was used. Temperature of the sample was controlled by flow of
nitrogen or air regulated at 3 or 200C, respectively, over the sample. Some
of the experiments were performed on a 2 T superconductor magnet using
a Bruker/GE CSI II NMR spectrometer/imager operating at 35CI resonance
frequency 7.9 MHz (85 MHz for protons). Experiments were done at room
temperature using a probe with a 12 mm diameter radio frequency coil.
For both spectrometers, the sweep width was 2000 Hz, and there were
256 points collected for each scan. The signal averages varied according to
the concentration of Cl- and LB of the sample. The typical range was 100
to 1000 scans requiring 14.8-148 s, respectively. An extra line broadening
of 10 Hz was added to all spectra to improve signal/noise ratio. The
original data set was zero-filled to 8192 data points before Fourier trans-
formation. The linewidth was calculated by fitting the spectrum to a
Lorentzian function after removal of any baseline offset. Shimming was
done on the water proton signal of buffer. Solvent proton-linewidth was
3-5 Hz for buffer and 12-15 Hz for red cell samples.
Treatment with inhibitors
The treatment with EM (Molecular Probes, Inc., Eugene, OR) was carried
out in the dark at 370C in 150 KH buffer (pH = 6.71 at 370C). To obtain
more than 99% inhibition of Cl- exchange, the cells were treated with 300
,uM EM in 150 KH at 10% hematocrit for 2 h (Liu and Knauf, 1993).
To achieve nearly complete binding of band 3 with DNDS, enough
DNDS was added to the samples to achieve more than 98% inhibition of
Cl- exchange. Based on the measurement that ID50 for DNDS is 4.11 ,AM
in 150 mM Cl- medium (Knauf et al., 1993b), the final concentration of
DNDS in the extracellular volume was at least 400 ,uM. After adding
DNDS, the samples were usually measured within 8 h to avoid lysis that
might make the LB abnormally large. Treatment with other inhibitors is
described in the figure legends.
Nystatin treatment
To vary the Cl- concentration both outside and inside the cells, nystatin
was used to increase the cation permeability of the membrane, so that
cations and Cl- could equilibrate as previously described (Knauf et al.,
1989; Knauf and Brahm, 1989). The cells were loaded with medium
containing 10, 20, 50, 100, or 200 mM Cl- by incubating with 30 ,ug/ml
nystatin at 0°C for 10 min. When the osmolarity difference between the
starting and final media was large, several steps were used to bring the Cl-
concentration down. In order to avoid severe lysis, we always kept the ratio
of osmolarity between two consecutive treatments <1.6. After each treat-
ment, the samples were spun down and the supernatant was removed by
aspiration. After the nystatin treatment, the cells were washed at least five
times in the final medium to remove nystatin. There was a 5-min incuba-
tion at room temperature before each wash.
36CI flux experiments
To measure the effect of inhibitors on Cl- exchange, cells were loaded
25% hematocrit for 5 min at room temperature. Then the samples were
stored on ice before measurement of Cl- exchange as described by Dal-
mark and Wieth (1972).
Data analysis
The NMR data were processed with the spectrometer software. The radio-
active isotope flux data were analyzed by using an Excel (Microsoft, PC
version) spreadsheet. The Cl- exchange rate constant was determined from
a least-squares fit of the data to a two-compartment isotope exchange
model (Gunn and Frohlich, 1989).
RESULTS AND DISCUSSION
Characteristics of the intact cell system
Cl- can bind to both the inside and the outside of the red
cell membrane. In leaky red cell ghosts, binding sites on
both sides of the membrane give rise to line broadening
(Falke et al., 1984a,b). Under normal conditions, the num-
bers of band 3 in the inward- and outward-facing confor-
mations are different, and the 35Cl relaxation properties in
these two types of binding sites might also be different. To
selectively detect LB effects of the outward-facing confor-
mation, we used intact cells instead of red cell ghost mem-
branes. Intact red blood cells have a very high concentration
of hemoglobin, which binds Cl- and greatly broadens the
NMR spectral linewidth for intracellular Cl- (Forsen and
Lindman, 1981). The effect of line broadening inside the
cells is such that the Cl- signal from inside the cell decays
before data acquisition begins, and the observed signal is
entirely from extracellular 35Cl (Falke et al., 1984b). Fur-
thermore, the Cl- exchange rate across the cell membrane is
much slower than the relaxation rate of the extracellular
35Cl NMR signal (Brahm, 1977), which ensures that the
exchange rate of extracellular Cl- with intracellular Cl-
does not contribute to our LB signal. To verify this, we used
a noncompetitive inhibitor, niflumic acid, that inhibits Cl-
transport but does not prevent binding of Cl- to the trans-
port site (Falke and Chan, 1986c). The LB of niflumic
acid-treated cells did not decrease compared with that of
control (data not shown), indicating that no significant por-
tion of the LB is related to transport of Cl- across the
membrane. Thus, with intact cells, only the external Cl-
binding sites account for the LB observed. This system has
an obvious advantage over using ghost membranes if one
wishes to see whether an inhibitor blocks the external access
channel.
For quantitative analysis of the data, it is usual to assume
that the number of binding sites is far less than the number
of free anions (Bull, 1972). In our studies, the lowest Cl-
concentration used was 10 mM. At 50% hematocrit, the
band 3 protein concentration is about 1.66 X 10-2 mM
(expressed in terms of mol/l of extracellular solution). Thus,
the Cl- concentration is 500 times greater than the number
of sites, so the assumption is valid even for the lowest Cl-
with 2.0 ,uCi/ml 36C1 (ICN Radiochemicals, Irvine, CA) by incubation at
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Relation of LB to hematocrit
To get an appreciable LB signal, we need to use a high cell
concentration (-50%). The cell volume must be excluded
in the data analysis because the signal from chloride inside
the cells is not observed. Fig. 2 shows the relation between
LB and cell concentration expressed in terms of hematocrit,
h (volume of cells/volume of suspension). [Cl]B in Eq. 1 is
proportional to h and [Cl]T is proportional to (1 - h), so
h/(l - h) is proportional to [Cl]B/[Cl]T. LB is proportional
to h/(l - h) at low hematocrit as expected from Eq. 1, but
the LB levels off when h > 0.5 (data not shown).
This effect is explained by the fact that the shape of the
NMR spectrum is not a perfect Lorentzian function. Under
this circumstance, the single Lorentzian fit to the spectra is
only an approximation, and the spectra are better repre-
sented by two Lorentzian functions that are superimposed
but have different linewidths. Thus, the free induction decay
signal can be better fitted by a biexponential function (Price
et al., 1991; Liu, 1995). The two components arise from
separate transitions within the 3/2 spin system (Bull, 1972)
and will be discussed in detail in a future publication. At
lower hematocrit, the difference between the linewidths for
the two components is small enough that the signal can be
well approximated by a single component. At higher he-
matocrit, the difference becomes larger and the single ex-
ponential approximation leads to an underestimate of LB
and to a distortion of the linear relationship at high hemat-
ocrit. This effect does not exist in DNDS-treated cells at
20°C, which indicates different properties of the transport
site and the low affinity DNDS-insensitive site (see below).
In practice, we kept the hematocrit as consistent as pos-
sible for the samples that were compared with each other to
avoid using a correction curve that might introduce an
additional systematic error. The small variations of hema-
tocrit around 50% were corrected by an empirical equation
in which h/(l - h/3) instead of h/(l - h) is used, because
this gives the most linear result.
35f
FIGURE 2 Linewidth of red blood cell samples
with different hematocrits (h) is plotted as a function
of h/(l - h). The result is consistent with the predic-
tion that the Cl- signal inside the cells is invisible.
Measurements were done on the low field (2 T) spec-
trometer at room temperature. Cells were suspended in
150 KH medium. Three or four values from different
experiments were averaged to give each point. Cells
were not necessarily from the same donor, so the error
bars (SD) include variation among different donors.
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Separation of low affinity and high affinity sites
Besides the transport sites on band 3 protein that can bind
Cl-, there are other sites on the surface of the membrane
that can also bind Cl- and give rise to LB. According to Eq.
1, the total LB can be written as:
[X1] [X2]
LBTotal = a1 [Cl] + Kdl + a2 [Cl] + Kd2 (2)
Subscript 1 stands for the parameters for transport sites and
subscript 2 for those corresponding to other sites. The
transport sites have a higher affinity for Cl-, and the LB due
to Cl- binding to the transport sites can be eliminated by
adding DNDS, which behaves like a competitive inhibitor
of band 3-mediated CF- exchange (Frohlich, 1982). DNDS
also binds with lower affinity to a noncompetitive inhibitory
site (S. J. Liu, E. A. Ries, and P. A. Knaupf, submitted for
publication; Knauf et al., 1993a). This binding cannot take
place when the higher affinity competitive site is occupied,
so under most conditions DNDS will be bound to the
noncompetitive inhibitory site in only a small fraction of
the total number of band 3 molecules.
The DNDS-insensitive LB comes from Cl- binding to
low affinity sites (Kd >> 0.5 M) (Falke et al., 1984a,b). This
Kd is much larger than the physiological Cl- concentration,
so Kd2 >> [Cl] in Eq. 2. Thus Eq. 2 can be simplified as:
[XJ] [X2]
LBTOtal a1 [CI] + Kdl 2 Kd2
(3)
[XJ]
al [Cl] + Kdl + LBDNDS-
Because the term for DNDS-insensitive LB is independent
of [Cl], and hematocrit is constant (i.e., [X2] is constant),
this term is represented by a constant, LBDNDS. Thus, the
difference between LB for control and DNDS-treated sam-
1.2
h/(1-h)
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ples, LBTotal
-LBDNDS, gives the LB due to Cl binding to
transport sites (Eq. 3).
Table 1 gives LB of control and DNDS-treated cells in
media containing 150 or 50 mM Cl- at 3 or 20°C. Although
the DNDS-sensitive LB in Hz is similar at different tem-
peratures, the buffer linewidth increases from 13.1 ± 0.7 Hz
to 19.9 ± 0.4 Hz when the temperature changes from 20°C
to 3°C and the DNDS-insensitive LB also increases. There-
fore, the DNDS-sensitive LB (at 150 mM CF-) represents a
larger portion of the total linewidth at 20°C (33%) than at
0°C (21%).
The effect of cell lysis
As stated above, the high concentration of hemoglobin
inside the cells suppresses the chloride signal from inside
and simplifies the system. On the other hand, the hemoglo-
bin released from lysed cells can cause additional line
broadening of the Cl- outside the cells. This effect could
interfere with our observations of LB associated with the
transport site.
When we measured the LB of supematant from the cell
samples, however, the average LB of supernatant from
control cells was 3.2 ± 1.2 Hz, whereas that from DNDS-
treated cells was 4.0 1.5 Hz. The additional DNDS-
sensitive LB caused by cell lysis is thus -0.8 ± 1.9 Hz.
This number is not significantly different from 0 and is
comparable to the total experimental standard error, -1 Hz.
In our studies, therefore, we did not correct the LB for cell
lysis. However, measures have been taken to reduce cell
lysis in several ways, such as reducing the time each sample
has to wait before NMR measurement and handling samples
with care. Because lysis increases with time, we designed
our experiments so that all NMR measurements can be done
within 36 h from the time the blood is drawn. Low temper-
ature reduces cell lysis, so the samples were kept on ice as
long as possible before the NMR measurements.
LB in EM-treated cells comes from both high and
low affinity sites
Fig. 3 shows the inhibition of Cl- exchange resulting from
covalent reaction of band 3 with EM. Under the conditions
of our experiments, the flux was inhibited more than 99%.
Liu and Knauf (1993) observed that the residual flux could
be further inhibited by treatment with 4,4'-diisothiocyano-
0.05-
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c
0
a
x
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FIGURE 3 Effect of EM treatment on Cl- efflux measured by 36C1
exchange rate constant. Cells were pretreated with 300 or 100 ,M EM at
10% hematocrit at 37°C for 2 h and then washed at least three times with
150 KH to remove unreacted EM. Fluxes were done at 0°C in 150 KH
medium.
stilbene-2,2'-disulfonic acid (DIDS), an inhibitor that is
mutually exclusive with EM (i.e., both cannot be bound at
the same time) so it can only react with band 3 molecules
that have not been labeled by EM. The residual flux is only
0.13% after further treatment with DIDS (Liu and Knauf,
1993). This suggests that the -1% residual flux in Fig. 3
represents unreacted band 3 and that once band 3 is labeled
by EM, it is inhibited nearly completely. Because the fluc-
tuation of the DNDS-sensitive NMR LB signal due to
experimental error is in the range of 10% of the measured
value, the 1% unreacted band 3 should not significantly
affect our measurements.
Although the labeling of band 3 with EM dramatically
decreases Cl- flux (Fig. 3), the 35Cl NMR LB of EM-
treated cells is not significantly decreased compared with
that of control cells (Table 1). It is obvious that the LB of
EM-treated cells is significantly greater than the LB caused
only by low affinity sites, i.e., the LB with DNDS present.
This throws doubt on the suggestions that EM inhibits by
blocking the external anion access channel, because such
blockage should eliminate LB due to the transport sites.
However, this observation alone cannot prove that transport
TABLE I Comparison of control, EM, and DNDS LB at 3 and 200C in 150 and 50 mM Cl- medium
150 mM Cl- 50 mM Cl-
Temperature Control EM DNDS Control EM DNDS
30C 19.0 ± 1.2 16.2 ± 2.5 11.1 ± 0.7 19.5 ±- 0.7 18.1 ± 0.6 10.6 + 1.2
200C 14.8 ± 0.6 13.3 + 1.0 5.2 + 0.8 16.0 ± 1.7 16.3 ± 0.5 6.5 ± 1.2
LB is measured in Hz. Each value represents the average and standard deviation for three to five samples. Control stands for the samples without any
inhibitor treatment. EM refers to cells that were treated with 300 ,uM EM for 2 h at 370C followed by three to five washes to remove unreacted EM. DNDS
stands for samples containing 500 ,tM DNDS. All samples were adjusted to 50% hematocrit before NMR measurement.
0.06 c
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sites are still accessible to free Cl- in t]
after the band 3 is labeled by EM. The
result might also be obtained if EM
transport-site-related LB just enough to
decrease in LB due to EM blocking the a
To distinguish these alternatives, we
much of the total LB of EM-treated cel
to the transport site. Unfortunately, wi
we could not separate the two kinds of
as with control cells, because EM and ]
exclusive (Knauf et al., 1993b). We the]
ent approach in which we changed the (
both sides of the membrane and measu
treated cells (Fig. 4). As in control cel
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he external medium total LB of EM-treated cells decreases with increasing Cl-
same experimental concentration. If the LB of EM-treated cells were totally due
increases the non- to low affinity sites, the LB would be almost completely
compensate for the insensitive to Cl- concentration (Eq. 3). By fitting the total
nion access channel. LB of EM-treated cells to Eq. 3, we can separate the LB of
need to know how EM-treated cells into two components, one for high affinity
[Is is due to binding sites and one for low affinity sites (Fig. 4, A and B), just as
ith EM-treated cells in untreated control cells. LBDNDs represents the LB of low
LB by using DNDS affinity sites and is calculated to be 6.8 ± 1.8 Hz at 20°C
DNDS are mutually and 9.7 ± 1.6 Hz at 3°C, not significantly different from the
refore used a differ- measured DNDS-insensitive LB for control cells, which is
-Il concentration at 6.3 ± 1.0 Hz (20°C) or 9.9 ± 2.1 Hz (3°C). This indicates
ired the LB of EM- that low affinity site LB does not change after EM treatment
[ls, a portion of the and that high affinity sites are present even though the flux
is inhibited by more than 99%. This result strongly suggests
that Cl- can still bind to the transport site after EM labeling.
As a reversible inhibitor, EM binds five times more
strongly to the E. form of band 3, with the transport site
empty and facing outward, than to the Ei form, with the
transport site facing inward (Knauf et al., 1993b). Because
most of the unloaded transport sites face inward under
normal conditions (Knauf and Brahm, 1989), one might
therefore expect EM treatment to increase the fraction of
band 3 molecules with the transport site facing outward, and
therefore to increase the LB, which should be proportional
to the number of outward-facing sites under our conditions.
The failure to observe an increase in LB could be ex-
plained in several ways. First, we do not know the relative
number of inward- (ECl1) and outward-facing (EClO) Cl-
loaded transport sites, nor do we know anything about the
150 200 preference of EM for EClI versus EClI. With 150 mM Cl-
present, most of the sites will be in the Cl-loaded form, so
no predictions about the effects of EM on site orientation
can be made under these conditions. Second, upon covalent
reaction EM might alter the site orientation. Third, EM
might alter the a factor for Cl-, which could have a com-
pensatory effect on the LB. As we will discuss below, the
rate of exchange between free and bound Cl- at the trans-
port site is slower in EM-treated cells, which will result in
a decreased value of a. Falke and Chan (1986c) observed
that niflumic acid, a translocation inhibitor that also prefers
Eo over Ei by about a factor of 5, also did not increase the
LB caused by intact cells. They interpreted this as probably
indicating that niflumic acid simply raises the free energy of
the transition state between the ECli and EClI forms,
thereby preserving the original orientation of transport sites.
150 ' 200 ' This interpretation may also apply to the situation with EM,
but other possibilities cannot be ruled out without further
information.
FIGURE 4 Effect of Cl- concentration on LB for EM-treated cells. The
hematocrit was 50%. Cells were treated with nystatin to bring [Cli] equal
to [ClO]. Error bars represent SD. The data were fitted to the function
LBTotal = a[X]/([CI] + Kd) + LBDNDS (Eq. 3) by a nonlinear least-squares
fitting, with each point weighted according to the reciprocal of its SD
squared (instrumental weighting). The Kd estimated from this set of data is
44 + 26 mM for 20°C (A) and 52 ± 30 mM for 3°C (B). The LBDNDS was
calculated to be 6.8 + 1.8 Hz (A) and 9.7 ± 1.6 Hz (B). All data were
collected with blood from a single donor.
Iodide competes with chloride in
EM-treated cells
Although the presence of EM prevents many inhibitors of
band 3, such as DNDS, from binding, a smaller molecule,
e.g., a substrate of the anion exchanger, might still bind to
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the transport site, if EM really does not block access to this
site. We used iodide as a competitive anion substrate and
measured the effect of iodide on the LB of chloride. The
results are shown in Fig. 5. Iodide competes with both
DNDS-sensitive (control - DNDS) and DNDS-insensitive
(DNDS) sites, because LB from both components decreases
when iodide is present. With the assumption that the low
affinity site LB was the same for control and EM-treated
cells at each I- concentration, the portion of LB corre-
sponding to the DNDS-sensitive LB in EM-treated cells
(EM - DNDS) also decreases when the iodide concentra-
tion is increased from 0 to 62 mM. This is similar to the
situation in control cells, and it indicates that I- competes
with Cl- for high affinity sites in both control and EM-
treated cells, further reinforcing the idea that the external
access channel is not blocked by EM.
The rate of Cl- exchange between medium and
transport site
Falke et al. (1985a) pointed out that the 35CI/37Cl LB ratio
provides some information about the exchange rate of CF-
18-
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14
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10*
8I
4
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0 -
* No Iodide
* Iodide
Control - DNDS EM DNDS DNDS
FIGURE 5 Iodide as a competitive anion in control and EM-treated
cells. The medium with iodide is 100 mM KCI, 62 mM KI, and 20 mM
HEPES; the medium without iodide is 100 mM KCI, 124 mM sucrose, and
20 mM HEPES. The experiment was performed at 20°C. "DNDS" indi-
cates the LB of cells exposed to 500 ,uM DNDS in the medium with
(Iodide) or without iodide (No iodide). "Control - DNDS" is obtained by
subtracting LB of DNDS-treated cells from the total LB of control cells,
which indicates the DNDS-sensitive LB. Assuming that EM does not affect
the low affinity site LB, we subtracted the LB of DNDS-treated cells from
total LB of EM-treated cells to obtain the result designated "EM -
DNDS". It shows that the portion of LB in EM-treated cells that corre-
sponds to DNDS-sensitive sites was also reduced by adding iodide. Note
that this donor has a higher than average LB for the low affinity sites.
between the binding sites and the external medium. The
exchange of CF- between a binding site and medium can be
slow, intermediate, or rapid compared with chloride T2 in
the bound environment. The 35C1 to 37CI LB ratio is close to
1 for the slow exchange condition, while it is 1.6 for rapid
exchange. The ratios for the LB from different types of sites
are different. The Cl- in free solution gives a 35C1 to 37C1
linewidth ratio close to 1.6, which is the limit for the
extreme fast exchange condition. The ratio for the high
affinity sites indicates that the exchange between free CF- in
the medium and CF- bound to the high affinity sites is near
the slow exchange limit (Falke et al., 1985a).
We measured the 35C1 to 37Cl DNDS-sensitive LB ratio
with control cells and observed that the ratio was 1.1 (200
mM [Cl], 3°C). Based on the assumption that the low
affinity site LB is the same for both control and EM cells,
the ratio for EM-treated cells was calculated to be 1.0 (200
mM [Cl], 3°C). Thus, the exchange in EM-treated cells is
even closer to the slow exchange limit than in control cells.
If the exchange of free CF- with bound CF- at the
transport sites is in the slow exchange limit, the LB is
proportional to the rate of exchange of bound CF- with CF-
in the solution. We can thus estimate the dissociation rate
constant, koff, if we know the probability that CF- is in the
bound state, PB (Falke et al., 1985a). The equation is:
koff = 7r X LB/PB. (4)
If we use the maximal value for PB, assuming that all band
3 molecules have CF- bound, we get a lower limit for kff,
as shown in Table 2. The k0ff values estimated for control
and EM-treated cells are very similar and much too large for
the exchange process to limit the transport rate. For exam-
ple, at 3°C in 150 KH medium, the translocation rate is 400
s'- (Brahm, 1977). To get 99% inhibition by slowing down
the exchange of CF- between medium and transport sites,
the koff should be <4 s-1 instead of the value 1.10 X 105
s-i calculated from the LB data. Therefore, it is impossible
for EM to inhibit CF- transport by slowing down (blocking)
the exchange of CF- between the external medium and the
transport sites.
Application of intact cell NMR to other inhibitors
The methods discussed here can be used to study the effect
of any inhibitor on Cl- binding to the outward-facing site.
Fig. 6 shows an experiment with DNDS and two other
inhibitors, tetrathionate and pyridoxal-5-phosphate (P5P). It
was shown previously that P5P could react both reversibly
and irreversibly with band 3 and inhibit anion transport
(Bar-Noy and Cabantchik, 1990; Salhany et al., 1987). In
this experiment, both inhibitors were used as reversible
inhibitors. The decrease of transport site LB is consistent
with the decrease of CF- flux (Fig. 7), which indicates that
they both inhibit either by blocking the external access
channel or by competing with Cl- for the transport site.
When the cells are pretreated with EM, none of the inhib-
20
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TABLE 2 Dissociation rate constants for control and EM-treated cells at 3°C
CI Concentration (mM) Control LB (Hz) EM LB (Hz) PB ([P]/[CI]) Control k,,ff 2 EM k(ff 2
50 9.74 10.08 3.32E -04 9.20E + 04 9.55E + 04
100 7.77 6.02 1.66E-04 1.47E + 05 1.14E + 05
150 7.57 3.86 1.11E -04 2.15E + 05 1.10E + 05
200 5.79 4.30 8.30E -05 2.19E + 05 1.63E + 05
Cell concentration was 50% hematocrit. "Control LB" was calculated by subtracting DNDS line width from total line width of corresponding control cells.
"EM LB" was obtained by subtracting LBDNDS (calculated in figure 4 B) from total line width of corresponding EM-treated cells. [PI is the estimated band
3 concentration, which is 16.6 ,tM at 50% hematocrit. koff was estimated from Eq. 4.
itors can decrease LB. This indicates that the binding sites
of all three inhibitors overlap with that of EM.
CONCLUSIONS
Previously we have argued that Lys-430, the residue with
which EM reacts, is not located at the external transport site
(Liu and Knauf, 1993). This was based on evidence that
reversible inhibition by EM is noncompetitive (Knauf et al.,
1993b) and that EM acts as an affinity label, reacting
covalently only after binding reversibly to band 3 (Liu and
Knauf, 1993). This evidence, however, could not rule out
the possibility that there is a change of conformation after
EM reaction, such that covalently bound EM overlaps the
transport site. Indeed, there is some evidence for a confor-
mational change, because covalent reaction with EM causes
16-
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NO other inhibitors
DNDS (250 uM)
Tetrathionate (10 mM)
P5P (10 mM)
much greater inhibition than does reversible binding (Knauf
et al., 1993b; Liu and Knauf, 1993). The present data show
that Cl- binding to the external transport site persists even
after covalent reaction with EM, thereby conclusively dem-
onstrating that intact Lys-430 is not required for Cl- bind-
ing. This conclusion is in accord with a previous mutagen-
esis study by Passow et al. (1992).
Earlier reports (Wyatt and Cherry, 1992; Passow et al.,
1992) suggested that EM may inhibit Cl- flux by restricting
Cl- access to the band 3 transport site (Fig. 1). Our results
indicate that Cl- can still bind to the transport site after the
cells are labeled by EM, demonstrating that a different
mechanism must be responsible for transport inhibition.
Evidence suggesting that EM does not directly block Cl-
binding to the inward-facing site of band 3 is provided by
the fact that EM binds to Lys-430 (Cobb and Beth, 1990),
which is located toward the outer surface of the membrane,
and that EM is not accessible to fluorescence-quenching
agents from the inside of the cells (Wyatt and Cherry,
1992). Although the possibility that Cl- binding at the
inward-facing site is inhibited by an allosteric effect cannot
be strictly excluded, it seems most probable that transport
inhibition occurs because EM does not allow band 3 to
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FIGURE 6 Application of intact cell 35C1 NMR to other inhibitors. Data
show the effects of three inhibitors, DNDS, P5P, and tetrathionate, on LB
of control and EM-pretreated cells. The fact that P5P does not totally
inhibit transport LB indicates a lower affinity compared with tetrathionate,
whose Kd is no more than 500 ,uM (Deuticke et al., 1978). For this figure
and for Fig. 7, concentrations are expressed per total volume of cell
suspension.
FIGURE 7 Effect of 10 mM P5P on LB and flux rate constant. 35C1
NMR spectral linewidths were measured at 20°C for control cells, 10 mM
pyridoxal-5-phosphate-treated cells (P5P), 10 mM tetrathionate-treated
cells (Tetrathio) and 250 ,uM DNDS-treated cells (DNDS). LB was cal-
culated by subtracting buffer linewidth from the total linewidth of the
corresponding samples. The hematocrit was 50% for all samples. Flux rate
constant was measured by 36Cl exchange at 0°C as described in Materials
and Methods. Error bars indicate SD of three to five samples.
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FIGURE 8 Proposed model for EM inhibition. The EM molecule does
not block the anion access channel (substrate can still bind to the transport
site), but the covalent reaction ofEM with band 3 prevents the protein from
undergoing the translocating conformational change, which is the rate-
limiting step in anion transport.
alternate between the outward- and the inward-facing con-
formations (Fig. 8). By freezing the band 3 conformation,
EM may provide a way to measure the true binding affinity
of CF- to the outward-facing transport site, because under
these conditions the effects of the transporting conforma-
tional change on the apparent affinity (Frohlich and Gunn,
1986) are eliminated.
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